Clinical Trials
1
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Walking Balance Training Post-Stroke
- Conditions
- Stroke
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2025-07-08
- Target Recruit Count
- 33
- Registration Number
- NCT06090604
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
News
FDA-Approved Menopause Drug Duavee Shows Promise for Breast Cancer Prevention in Phase 2 Trial
A multi-center phase 2 clinical trial led by Northwestern Medicine found that Duavee significantly reduced cell growth in breast tissue among 141 postmenopausal women with ductal carcinoma in situ (DCIS).
Predictive Models Show High Accuracy in Identifying Severe Pediatric Pneumonia Cases
Researchers developed predictive models that accurately distinguish mild, moderate, and severe community-acquired pneumonia in children aged 3 months to 14 years with a c-statistic of 0.82.
Mental Health Crisis Deepens: Anxiety and Depression Rates Surge Among Americans, Particularly Youth
Recent CDC data reveals a significant increase in anxiety rates among U.S. adults, rising from 15.6% in 2019 to 18.2% in 2022, with young adults aged 18-29 experiencing the highest prevalence at 26.6%.
Smartwatch Innovation: New Heart Rate-to-Step Ratio Emerges as Superior Health Indicator
Northwestern University researchers have developed a new health metric that divides average daily heart rate by step count, providing a more reliable measure of cardiovascular fitness than either measurement alone.
Jennifer Jao Appointed Co-Chair of IMPAACT Network to Advance Pediatric HIV Clinical Trials
Dr. Jennifer Jao of Northwestern University will co-chair the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Network.
Eflornithine Plus Lomustine Improves Survival in IDH-Mutant Anaplastic Astrocytoma
The phase 3 STELLAR trial demonstrated that eflornithine combined with lomustine significantly improved survival in patients with recurrent _IDH_-mutant anaplastic astrocytoma.
Study Examines Link Between Testosterone Replacement Therapy, Atrial Fibrillation, and Acute Kidney Injury
A recent study presented at the 2024 SMSNA Annual Meeting investigated the association between testosterone replacement therapy (TRT) and the risks of atrial fibrillation and acute kidney injury.
Weight Regain Common After Stopping GLP-1 Agonists, Trials Show
Clinical trials reveal that patients often regain weight after discontinuing GLP-1 agonists like semaglutide and tirzepatide, underscoring obesity's chronic nature.